MOTS-C
Batch #010001 · Research use only.
High purity research peptide for scientific applications
MOTS-C is a mitochondria-encoded peptide that has gained significant attention in research for its role in regulating metabolic homeostasis, insulin sensitivity, and adaptive stress responses. Unlike nuclear-encoded peptides, MOTS-C originates from mitochondrial DNA and is studied for its unique ability to influence cellular energy balance and metabolic signaling.
Product overview
MOTS-C is a research-grade peptide composed of a 16-amino-acid sequence encoded within the mitochondrial genome. Preclinical and early clinical research associate MOTS-C with improved metabolic flexibility, enhanced glucose utilization, and activation of pathways related to cellular stress adaptation and longevity. Its mitochondrial origin makes it a valuable tool for studying energy regulation at the cellular level.
Key research features
Mitochondrial and metabolic regulation:
MOTS-C is widely studied for its potential to enhance mitochondrial efficiency and regulate metabolic pathways involved in glucose and lipid metabolism. Research models explore its role in supporting energy balance and metabolic health.
Insulin sensitivity and glucose utilization:
Studies suggest MOTS-C may improve insulin signaling and glucose uptake in experimental models, making it relevant for research focused on metabolic dysfunction, insulin resistance, and energy homeostasis.
Cellular stress and longevity pathways:
Research indicates MOTS-C may activate adaptive stress response pathways, including those associated with AMPK signaling, contributing to cellular resilience and longevity-related mechanisms.
MOTS-c Suggested Use:
Typical Dose: 5–10 mg per day
Route: Subcutaneous injection
Frequency: Once daily
Duration: 6–12 weeks per cycle, or as recommended by a healthcare professional